Screener
Odyssey Therapeutics ODTX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Odyssey Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335822
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (20) | (2) | (30) | (4) |
| Other expense, net | (138) | (154) | (255) | (443) |
| Total other income, net | 2,674 | 716 | 4,255 | 1,581 |
| Loss before income taxes | (52,796) | (41,205) | (90,995) | (79,500) |
| Income tax provision | (8) | 30 | 55 | 170 |
| Net loss | $(52,788) | $(41,235) | $(91,050) | $(79,670) |
| Other comprehensive (loss) income: | ||||
| Foreign currency translation adjustment | 113 | 1,314 | (193) | 1,889 |
Item 1. Financial Statements.
FAQ
- What is Odyssey Therapeutics's pre-tax income?
- Odyssey Therapeutics (ODTX) reported pre-tax income of -$52.8M in Q2 2026.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Odyssey Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude